Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Hemangioma, Capillary × Propranolol × Clear all

Phase

Phase 3 3 Phase 2/3 2 Phase NA 1 Phase 4 1

Status

Recruiting 1 Completed 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Hemangioma, Capillary 2 Ulcer 1 Recurrent respiratory papillomatosis 1 Papilloma 1 Melanoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06798363 2026-03-16

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

West China Hospital

Phase 2/3 Recruiting

Ulcer, Hemangioma, Capillary

NCT01056341 2015-12-10

Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy

Pierre Fabre Dermatology

Phase 2/3 Completed

512 enrolled 13 charts

Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡